<DOC>
	<DOCNO>NCT02556268</DOCNO>
	<brief_summary>To investigate pharmacokinetic drug-drug interaction potential fix dose antiretroviral therapy , i.e . ATRIPLA , COMPLERA , STRIBILD , TRIUMEQ , approve antiretroviral protease inhibitor combination ( preferably ) TRIUMEQ , exposure riociguat HIV patient stable dose one therapy . â€¢ To Assess safety tolerability riociguat treatment combination fixed-dose antiretroviral therapy .</brief_summary>
	<brief_title>Interaction With HIV Antiretroviral Agents</brief_title>
	<detailed_description />
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Elvitegravir , Cobicistat , Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Emtricitabine , Rilpivirine , Tenofovir Drug Combination</mesh_term>
	<mesh_term>Efavirenz , Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<mesh_term>Anti-Retroviral Agents</mesh_term>
	<criteria>Male female patient age &gt; =18 &lt; 65 year confirm diagnosis HIV receive stable regimen ATRIPLA , COMPLERA , STRIBILD , TRIUMEQ , approve antiretroviral protease inhibitor atazanavir , darunavir , indinavir , ritonavir , saquinavir combination ( preferably ) TRIUMEQ consistent recent prescribe information document least 6 week concomitant administration single oral dose 0.5 mg riociguat No clinical evidence pulmonary hypertension Written inform consent Severe diseases assumed pharmacokinetics effect study drug normal History coronary artery disease Symptomatic postural hypotension ( e.g . dizziness , lightheadedness ) History bronchial asthma airway disease Renal impairment creatinine clearance &lt; 15 mL/min Severe hepatic impairment ( ChildPugh class C ) Systolic blood pressure 100 mmHg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Single-Dose , Open-Label , Non-Blinded , Non-Placebo-</keyword>
	<keyword>Controlled , Stratified Design</keyword>
</DOC>